Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy-Reference-Cited by-同舟云学术

Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy

Published:2013-02-22 Issue:3 Volume:161 Page:411-423
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Kuter David J.¹,Bussel James B.²,Newland Adrian³,Baker Ross I.⁴,Lyons Roger M.⁵,Wasser Jeffrey⁶,Viallard Jean-Francois⁷,Macik Gail⁸,Rummel Mathias⁹,Nie Kun¹⁰,Jun Susie¹⁰

Affiliation:

1. Massachusetts General Hospital; Boston; MA; USA

2. Division of Hematology; Departments of Pediatrics and Medicine; Weill Medical College of Cornell University; New York; NY; USA

3. Department of Haematology; The Royal London Hospital; Whitechapel; London; UK

4. Centre for Thrombosis and Haemophilia; Royal Perth Hospital; Murdoch University; Perth; WA; Australia

5. Cancer Care Centers South Texas/US Oncology; San Antonio; TX; USA

6. Division of Hematology-Oncology; Department of Medicine; University of Connecticut School of Medicine; Farmington; CT; USA

7. Université Victor Segalen Bordeaux 2; Hôpital Haut-Lévêque; CHU de Bordeaux; Pessac; France

8. University of Virginia; Charlottesville; VA; USA

9. Klinikum der Justus-Liebig-Universität; Giessen; Germany

10. Amgen Inc.; Thousand Oaks; CA; USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12260/fullpdf

Reference32 articles.

1. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance;Ballem;Journal of Clinical Investigation,1987

2. Thrombocytopenia. I. Incidence and aetiology;Bottiger;Acta Medica Scandinavica,1972

3. Evaluation of bone marrow reticulin in patients with chronic immune thrombocytopenic purpura (ITP) treated with eltrombopag -data from the EXTEND study;Brynes;Blood (ASH Annual Meeting Abstracts),2011

4. A longitudinal prospective study evaluating the effects of eltrombopag treatment on bone marrow in patients with chronic immune thrombocytopenia: interim analysis at 1 year;Brynes;Blood (ASH Annual Meeting Abstracts),2012

5. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP;Bussel;New England Journal of Medicine,2006

Cited by 223 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune thrombocytopenia: literature review;Oncohematology;2024-09-01

2. Alternative Dosing of Eltrombopag for the Treatment of Chronic, Steroid-Refractory Immune Thrombocytopenia;Cureus;2024-06-26

3. Treatment of Immune Thrombocytopenia: Contextualization from a Historical Perspective;Hematology Reports;2024-06-26

4. Safety and efficacy of danazol in immune thrombocytopenia: a systematic review;Research and Practice in Thrombosis and Haemostasis;2024-05

5. Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia;Blood Advances;2024-03-29